1. Home
  2. Live Updates
  3. European medicines agency

Live Breaking News & Updates on European medicines agency

Stay informed with the latest breaking news from European medicines agency on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in European medicines agency and stay connected to the pulse of your community

US Approves Gene Therapy Treatment For Hemophilia

US Approves Gene Therapy Treatment For Hemophilia
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Canada , Washington , United-states , Adam-cuker , Thrombosis-program , European-medicines-agency , University-of-pennsylvania-comprehensive-hemophilia , Pfizer , World-federation-of-hemophilia , Comprehensive-hemophilia , World-federation , European-medicines

Frontline Amivantamab Plus Chemo Receives Positive EU CHMP Opinion for EGFR Exon 20 Insertion+ NSCLC

Frontline amivantamab with chemotherapy has been recommended for approval by the CHMP in EGFR exon 20 insertion+ non–small cell lung cancer.

Saint-quentin , Champagne-ardenne , France , Paris , France-general- , Henar-hevia , Kiran-patel , Nicolas-girard , Institut-curie , Curie-montsouris-thorax-institute , Clinical-development , Johnson-research-development

CHMP Recommends Frontline Nivolumab Plus Chemo in Unresectable/Metastatic Urothelial Carcinoma

Frontline nivolumab plus chemotherapy has been recommended for approval in unresectable or metastatic urothelial carcinoma.

Dana-walker , Bristol-myers-squibb-opdivo , European-commission , European-union , Bristol-myers-squibb , European-medicines-agency , Medicinal-products , Human-use , New-england-journal , Genitourinary-cancers ,

Fruquintinib Receives Positive CHMP Opinion for Previously Treated mCRC

CHMP has voiced its support for the approval of fruquintinib in previously treated metastatic colorectal cancer.

China , Chinese , European-medicines-agency , Medicinal-products , Human-use , European-medicines ,

Drug for Overactive Bladder Recommended in Europe

Obgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.

European-medicines-agency , Committee-for-medicinal-products-human-use , European-commission , Medicinal-products , Human-use , Pierre-fabre , Overactive-bladder-oab , Urinary-incontinence , Nonsurgical-therapies-for-urinary-incontinence , Bladder , Rinary-bladder

Two Biosimilars Approved in Europe for Autoimmune Disorders

The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's disease.

Ukraine , China , Bulgaria , Poland , Georgia , United-states , European-union , Medicinal-products , Human-use , European-medicines-agency , Rheumatoid-arthritis-ra

New Contraindications to Coadministration of Atazanavir

New restrictions have been imposed by the European Medicines Agency on the coadministration of the anti-HIV drug atazanavir with a variety of other agents.

Bristol-myers-squibb , European-medicines-agency , European-commission , Committee-for-medicinal-products-human-use , Medicinal-products , Human-use , Hiv-infection , Iv-disease , Iv , Hiv-antiretroviral-therapy , Ntiretroviral-therapy-for-hiv

EMA Approves Factor VIII Deficiency Clotting Drug

European Union marketing authorization recommended for Altuvoct for hemophilia A caused by factor VIII deficiency.

European-medicines-agency , European-commission , Committee-for-medicinal-products-human-use , Medicinal-products , Human-use , Swedish-orphan-biovitrum , Hemophilia-haemophilia , Factor-viii , Pain-management , Europe , Uropean

FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia - Pfizer (NYSE:PFE)

FDA approves Pfizer's Beqvez for adults with hemophilia B, offering a one-time treatment to produce FIX. Experience reduced bleeding frequency. Explore Pfizer's warranty program.

Canada , Australia , Australian , Pfizer-inc , European-medicines-agency , Reuters , Pfizer ,

Gilead writes $2.4B off Trodelvy as CEO underscores focus

Gilead writes $2.4B off Trodelvy as CEO underscores focus
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-states , Tennessee , American , Johanna-mercier , Merdad-parsey , Andrew-dickinson , Merck-keytruda , Daiichi-sankyo , Astrazeneca , Gilead-sciences , European-medicines-agency , American-society-of-clinical-oncology